Literature DB >> 29363793

Signature microRNAs of nuclear Sm complex associated with breast cancer tumorigenesis.

Xinyi Zhang1, Bo Shen1, Yalei Cui2.   

Abstract

It is well known that Sm proteins, small nuclear ribonucleoproteins, act as core spliceosomal factors in alternative splicing of mRNA precursors. MicroRNAs (miRNAs) can function in alternative splicing by targeting mRNAs of splicing factors. However, the direct interaction between miRNAs and proteins of splicing complex in nucleus has not been explored. In this study, the mature miRNAs in nuclear Sm complex of breast cancer cells and normal breast epithelial cells were characterized. Small RNA sequencing of immunoprecipitated nuclear Sm complex with the SmD1-specific antibody identified 123 and 170 mature miRNAs in nuclear Sm complex of normal breast cells and breast cancer cells, respectively. The results of Northern blot analysis confirmed the existence of mature miRNAs in Sm complex and electrophoretic mobility shift assay (EMSA) validated the binding of miRNAs with proteins of Sm complex. Among the identified miRNAs bound to the Sm complex in nucleus, 94 miRNAs were significantly upregulated, and 39 miRNAs significantly downregulated in breast cancer cells compared with normal breast cells, suggesting that miRNAs in nuclear Sm complex might be associated to tumorigenesis of breast cancer by regulating Sm complex during alternative splicing of mRNA precursors. Our study provided novel clues to reveal the regulatory mechanism of Sm complex in the assembly of spliceosome and contributed novel aspects of miRNAs to tumorigenesis of breast cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sm complex; breast cancer; miRNAs

Mesh:

Substances:

Year:  2018        PMID: 29363793     DOI: 10.1002/jcb.26697

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  miR-7/EGFR/MEGF9 axis regulates cartilage degradation in osteoarthritis via PI3K/AKT/mTOR signaling pathway.

Authors:  Lifeng Jiang; Xindie Zhou; Kai Xu; Pengfei Hu; Jiapeng Bao; Jin Li; Junfeng Zhu; Lidong Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Tumor suppressor miR-449a inhibits the development of gastric cancer via down-regulation of SGPL1.

Authors:  Qian Chen; Zhen Yang; Gaofeng Pan; Hongjian Ding; Daowen Jiang; Jianfang Huang; Weiyan Liu
Journal:  RSC Adv       Date:  2018-07-19       Impact factor: 4.036

3.  MBD1/HDAC3-miR-5701-FGFR2 axis promotes the development of gastric cancer.

Authors:  Changan Zhao; Jiyu Miao; Ruifang Sun; Rui Liang; Wenhu Chen; Yi Gao; Xiaofei Wang; Shuiping Han; Wenbao Zhao; Ting Lei; Chen Huang
Journal:  Aging (Albany NY)       Date:  2022-07-22       Impact factor: 5.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.